Publication | Open Access

CD19-targeted chimeric antigen receptor T-cell therapy for CNS relapsed or refractory acute lymphocytic leukaemia: a post-hoc analysis of pooled data from five clinical trials

Cell TherapyMedicineImmunologyClinical TrialsPost-hoc AnalysisAutoimmunityAdult T-cell Leukemia-lymphomaImmunotherapyOncologyRadiation OncologyHealth Sciences